Skip to main content

ADVERTISEMENT

Nipun Arora, MD

Commentary
06/02/2010
   While the clinical presentation of target lesion revascularization (TLR) following bare-metal stent (BMS) placement was previously perceived to be “benign,” several studies have now shown that BMS restenosis may present as acute coronary...
   While the clinical presentation of target lesion revascularization (TLR) following bare-metal stent (BMS) placement was previously perceived to be “benign,” several studies have now shown that BMS restenosis may present as acute coronary...
   While the clinical...
06/02/2010
Journal of Invasive Cardiology
Case Report
08/01/2008
Late stent thrombosis (occurring more than 30 days after stent placement), is a catastrophic complication of drug-eluting stents (DES) that has recently gained heightened awareness. It has been reported to occur at a rate of 0.6% per year...
Late stent thrombosis (occurring more than 30 days after stent placement), is a catastrophic complication of drug-eluting stents (DES) that has recently gained heightened awareness. It has been reported to occur at a rate of 0.6% per year...
Late stent thrombosis (occurring...
08/01/2008
Journal of Invasive Cardiology
Review
12/02/2008
Congenital heart disease (CHD) is a major public health problem that is largely underrecognized. Surgical and medical advances over the past decades have dramatically improved the once bleak prognosis of patients with CHD. Eighty-five percent...
Congenital heart disease (CHD) is a major public health problem that is largely underrecognized. Surgical and medical advances over the past decades have dramatically improved the once bleak prognosis of patients with CHD. Eighty-five percent...
Congenital heart disease (CHD)...
12/02/2008
Journal of Invasive Cardiology